Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
22-Jun-2026 | 555.9 | 558.8 | 526 | 540.5 | 25,462 | 25,29,78,492.45 | 2,36,342 |
23-Jun-2026 | 537.6 | 551.35 | 537.6 | 543.25 | 12,491 | 7,66,18,078.25 | 67,018 |
24-Jun-2026 | 543.25 | 558.8 | 538.6 | 553.2 | 11,022 | 10,42,99,630.2 | 1,21,715 |
25-Jun-2026 | 557.9 | 563.5 | 540.65 | 543.35 | 10,143 | 10,98,45,428.35 | 84,436 |
29-Jun-2026 | 544.3 | 554.6 | 516.25 | 523.8 | 44,995 | 57,21,78,791.75 | 6,92,051 |
30-Jun-2026 | 523.45 | 548.65 | 523.45 | 540.15 | 31,571 | 23,41,41,747.55 | 2,14,146 |
01-Jul-2026 | 540.15 | 549.9 | 532 | 541.6 | 13,210 | 8,46,96,471.1 | 88,072 |
02-Jul-2026 | 541.6 | 553 | 541.6 | 544.3 | 11,563 | 9,90,11,126.6 | 1,05,176 |
03-Jul-2026 | 544.95 | 559.1 | 544.3 | 556 | 15,347 | 16,31,91,614.45 | 1,80,703 |
06-Jul-2026 | 560 | 578 | 560 | 573.55 | 33,251 | 57,03,62,166.45 | 5,46,956 |
07-Jul-2026 | 577.9 | 578.75 | 563.1 | 566.15 | 20,726 | 17,46,37,327.35 | 1,83,412 |
08-Jul-2026 | 566 | 567.45 | 545.55 | 549.35 | 15,120 | 10,24,42,368.55 | 86,531 |
09-Jul-2026 | 549.35 | 564.4 | 548.8 | 560.05 | 9,045 | 5,91,04,537.1 | 56,219 |
10-Jul-2026 | 567 | 570.95 | 553.8 | 567.95 | 12,978 | 7,88,03,851.2 | 79,997 |
13-Jul-2026 | 568 | 571 | 557.6 | 564.7 | 10,319 | 4,85,58,046.6 | 39,371 |
14-Jul-2026 | 564 | 564.7 | 551.15 | 559.2 | 15,860 | 9,29,10,013.95 | 1,04,178 |
15-Jul-2026 | 563 | 585.4 | 559.7 | 571.65 | 33,561 | 40,44,69,972.15 | 3,95,288 |
16-Jul-2026 | 577.95 | 584 | 572 | 578.45 | 8,382 | 8,72,08,861.85 | 78,465 |
17-Jul-2026 | 580.85 | 583.35 | 540.05 | 545.3 | 18,545 | 18,07,77,618.95 | 1,69,216 |
20-Jul-2026 | 542.9 | 577 | 542.85 | 573.75 | 19,393 | 20,75,13,253.45 | 1,45,619 |
Metropolis Healthcare said it plans to expand its genomic test portfolio to more than 500 advanced tests over the next two to three years
The deal includes a deferred payment of ₹1.7 crore, which will be disbursed as per the terms of the business transfer agreement, the company said in a regulatory filing.
The EBITDA margin fell to 18% in Q4 FY25 from 24.2% in Q4 FY24, reflecting a fall in operational efficiency or profitability.
The EBITDA margin was stable at 22.3% and did not change much from the year-ago period.
This is a 100% stake purchase that will be funded through 55% cash and 45% equity swap. It expects completion in 60 days, after shareholders give their nod.
Here are some of the stocks that may see significant price movement today: Tata Motors, Asian Paints, Divi’s Laboratories, etc.
Here are some of the stocks that may see significant price movement today: Titan Company, HDFC Bank, IndusInd Bank, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
